# Nuclide record nct05655312 (trial). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/trials/nct05655312/>
  a schema:MedicalTrial ;
  nuclide:kind "trial" ;
  schema:identifier "nct05655312", "NCT05655312" ;
  schema:name "MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma"@en ;
  schema:description "A phase 1/2 trial of Nivolumab in melanoma, run by Perspective Therapeutics, now recruiting."@en ;
  schema:url <https://nuclide.cc/trials/nct05655312/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05655312> ;
  nuclide:status "recruiting" ;
  nuclide:tag "ctgov-ingest" ;
  nuclide:phase "1/2" ;
  nuclide:related <https://nuclide.cc/isotopes/pb-212/> ;
  nuclide:companies <https://nuclide.cc/companies/perspective-therapeutics/> .